What did you build this week? AI is continuing to be less like hype and more like implementation. The FDA is making it easier to implemet clinical trials and create medical devices using AI. AI is getting folded into the real mechanics of healthcare: clinical trials, Medicare coverage, cancer detection, and day to day workflow. The noise is dying down because people can organize the slop from meaningful advancements. The organizations moving fastest are the ones redesigning workflows around AI instead of bolting it onto existing systems.

What’s happening this week in AI

Plus: Organize your study materials and mazimize your learning

Let’s dive in.

🏛️ FDA and CMS Just Created a Faster Pathway for AI Enabled Devices: FDA and CMS announced the new RAPID pathway, designed to align regulatory review and Medicare coverage decisions earlier in the device development process. Eligible breakthrough devices may now move from authorization to national Medicare coverage in roughly two months instead of waiting close to a year. This is one of the clearest signs yet that federal agencies understand reimbursement delays are slowing adoption of clinically useful AI tools.
Why this Matters: Clinicians may start seeing validated AI enabled devices reach practice much faster, especially in imaging, diagnostics, and procedural workflows.

🧪 FDA Is Leaning Harder Into AI Assisted Clinical Trials: The FDA is reportedly piloting AI driven approaches designed to accelerate clinical trial workflows and improve evidence generation using real world data. Several groups are experimenting with AI systems that help identify eligible patients, simulate trial operations, and streamline recruitment bottlenecks. We are finally seeing regulators move from cautious observation into active experimentation.
Why this Matters: Faster and better trial enrollment could significantly reduce the timeline between discovery and bedside adoption.

🧬 Mayo Clinic’s AI Found Pancreatic Cancer Years Earlier: One of the most impressive clinical AI stories this week came out of Mayo Clinic. Their REDMOD model identified subtle pancreatic cancer signals on routine CT imaging up to three years before conventional diagnosis in many patients. In a retrospective analysis, the model flagged a large percentage of scans originally interpreted as normal, suggesting we may be getting closer to meaningful pre symptomatic detection for one of the deadliest cancers clinicians deal with.
Why this Matters: Pancreatic cancer outcomes remain poor largely because we detect it too late, so even modest gains in earlier detection could have massive downstream impact.

🤖 Physicians Performed Better With AI Literacy Training: Another recent study examined how physicians assessed AI generated clinical recommendations after structured AI literacy training. Clinicians who better understood model limitations appeared more capable of identifying unsafe or low quality outputs. This reinforces the idea that AI competency may soon become a core clinical skill rather than a niche interest.
Key Takeaway: Training clinicians to critically evaluate AI output may matter as much as the quality of the model itself.
- Preprint (not peer reviewed).

🧠 Safety Researchers Built a New Benchmark for Medical LLMs: The MedSafe Dx benchmark introduced adversarial clinical prompts designed to stress test medical AI systems around dosing, contraindications, and dangerous recommendations. Several leading models still struggled under adversarial conditions, especially when uncertainty was introduced into the prompt.
Key Takeaway: Safety evaluation is becoming just as important as raw accuracy for clinical AI deployment.
- Preprint (not peer reviewed).

🔐 The US Government Expanded AI Stress Testing for Frontier Models: Google DeepMind, Microsoft, and xAI agreed this week to allow US government researchers to evaluate advanced AI systems before public release. The evaluations focus on cybersecurity, biosecurity, and misuse risk, particularly for powerful frontier models that could eventually influence healthcare systems and critical infrastructure. This feels increasingly relevant for medicine as health systems become more dependent on large AI platforms.
Why this Matters: Healthcare organizations are going to demand more formal safety testing before deploying advanced AI systems into clinical operations.

🧪 FDA Asked for Public Input on AI Enabled Early Phase Clinical Trials: The FDA opened a formal request for information on a proposed pilot program exploring how AI could improve early phase clinical trials, including safety monitoring, dose selection, and faster go or no go decisions while maintaining regulatory standards. It is a useful signal that FDA is not just reviewing AI products, it is actively studying how AI may reshape the evidence pipeline itself.
Why this Matters: Trial design, safety review, and evidence generation are becoming part of the regulatory AI conversation, not just post market device oversight.

What it does: Creates grounded summaries and audio style overviews from uploaded sources.

I use this heavily for guideline review and long PDFs. I use it both for reviewing information as well as learning new information. You can upload multiple papers and manuscripts into one notebook and summarize them or compare study design or limitations, which is very useful. It creates flash cards, quizzes, and anything else you need to study.

Most importantly, it organizes the information in a way that is easy for me to read and understand.

https://notebooklm.google.com

Prompt to try:

The most important healthcare AI trend right now is not model capability. It is your capability to operate the model. The organizations pulling ahead are the ones figuring out governance, workflow integration, clinician training, and reimbursement all at the same time.

One practical takeaway this week: spend less time chasing the newest model and more time understanding where AI meaningfully removes friction in your daily work.

If this issue sparked an idea, send it to a colleague or reply with what your organization is actually deploying right now.